News

MedPage Today4m
Investigational Once-Weekly ART Combo Maintained Viral Suppression in HIV
An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
WHO recommends Gilead's twice-yearly injection for HIV prevention
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
HIV prevention gets an AI upgrade
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
New Study Shows How Providers Can Use Apretude To Prevent And Treat HIV In Black Women
A new study explores how healthcare providers can effectively implement Apretude for HIV pre-exposure prophylaxis (PrEP) ...
ViiV expands licence to allow generic HIV treatment production for low-income countries
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
STAT20h
ViiV expands licensing deal for its HIV drug in low-income countries
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
WVXU1d
Are UC researchers any closer to finding a functional cure for HIV?
This 2011 electron microscope image made available by the Centers for Disease Control shows HIV virions. On Wednesday, Sept.
Loss of $4M grant threatens HIV prevention efforts in Tennessee
This story was originally published by The Institute for Public Service Reporting Memphis. Healthcare providers across ...
Lisa Jarvis: When an HIV scientific breakthrough isn’t enough
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...